Skip to content
Resources > Reports

The Future of Primary Investment Research: An Evolution from Expert Networks to Expert Insights

While artificial intelligence (AI) has undoubtedly transformed the research landscape, AlphaSense recognizes that human experts still hold a crucial role in providing nuanced insights. By combining AI-driven efficiencies with granular insights from industry experts, AlphaSense’s Expert Insights is redefining how primary research is conducted.

Investment researchers are retiring traditional expert networks and incorporating powerful expert insights into their comprehensive research strategies. In this whitepaper, you will learn how:

  • Traditional investment research methods limit your research potential
  • AI technology can power up your primary investment research
  • Expert Call Services can fill in research gaps with granular insights

Download our whitepaper now to explore how AlphaSense continues to shape the future of primary investment research with Expert Insights.

Explore more

APAC Macro Briefing 2026: Risk Meets Opportunity

In this report, we show how resources and workflows available in the AlphaSense platform can help contextualize the APAC macro environment, exploring the key implications for corporate leaders and investors across sectors.
Title slide for "APAC Macro Briefing 2026: Risk Meets Opportunity" with a map of the Asia-Pacific region.

Top AI Use Cases for Private Equity

In this report, discover how private equity teams are leveraging AI to accelerate conviction with speed. With purpose built, AI-driven solutions like AlphaSense, teams are gaining a competitive advantage with custom workflows and unmatched content sets for the most differentiated deal intelligence.
Top AI Use Cases For Private Equity by Barb Tague, Financial Research Leader. Illustration featuring isometric buildings and currency symbols.

AI in Drug Development 2026: From Experimentation to Execution

Learn how AI is reshaping drug development in real time, turning AI execution into a key competitive differentiator.
Presentation slide titled "AI in Drug Development 2026: From Experimentation to Execution" by Sara Mallatt and Sean Carmichael, with line art of laboratory equipment.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.